The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study
Open accessAbstract
Background The CNS manifestations of COVID-19 in children have primarily been described in case reports, which limit the ability to appreciate the full spectrum of the disease in paediatric patients. We aimed to identify enough cases that could be evaluated in aggregate to better understand the neuroimaging manifestations of COVID-19 in the paediatric population. Methods An international call for cases of children with encephalopathy related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and abnormal neuroimaging findings was made. Clinical history and associated plasma and cerebrospinal fluid data were requested. These data were reviewed by a central neuroradiology panel, a child neurologist, and a paediatric infectious diseases expert. The children were categorised on the basis of their time of probable exposure to SARS-CoV-2. In addition, cases were excluded when a direct link to SARS-CoV-2 infection could not be established or an established alternate diagnostic cause could be hypothesised. The accepted referral centre imaging data, from ten countries, were remotely reviewed by a central panel of five paediatric neuroradiologists and a consensus opinion obtained on the imaging findings. Findings 38 children with neurological disease related to SARS-CoV-2 infection were identified from France (n=13), the UK (n=8), the USA (n=5), Brazil (n=4), Argentina (n=4), India (n=2), Peru (n=1), and Saudi Arabia (n=1). Recurring patterns of disease were identified, with neuroimaging abnormalities ranging from mild to severe. The most common imaging patterns were postinfectious immune-mediated acute disseminated encephalomyelitis-like changes of the brain (16 patients), myelitis (eight patients), and neural enhancement (13 patients). Cranial nerve enhancement could occur in the absence of corresponding neurological symptoms. Splenial lesions (seven patients) and myositis (four patients) were predominantly observed in children with multisystem inflammatory syndrome. Cerebrovascular complications in children were less common than in adults. Significant pre-existing conditions were absent and most children had favourable outcomes. However, fatal atypical CNS co-infections developed in four previously healthy children infected with SARS-CoV-2. Interpretation Acute-phase and delayed-phase SARS-CoV-2-related CNS abnormalities are seen in children. Recurring patterns of disease and atypical neuroimaging manifestations can be found and should be recognised being as potentially due to SARS-CoV-2 infection as an underlying aetiological factor. Studies of paediatric specific cohorts are needed to better understand the effects of SARS-CoV-2 infection on the CNS at presentation and on long-term follow-up in children. Funding American Society of Pediatric Neuroradiology, University of Manchester (Manchester, UK). Video Abstract Neuroimaging manifestations in children with SARS-CoV-2 infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513484547 · Cited by 1,130
The looming storm: Blood and cytokines in COVID-19
Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113
Cited by
LaRovere, K. L., Riggs, B. J., Poussaint, T. Y., Young, C. C., Newhams, M. M., Maamari, M., Walker, T. C., Singh, A. R., Dapul, H., Hobbs, C. V., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0504 · Cited by 396
Gomes, I. C., Karmirian, K., Oliveira, J., Pedrosa, C., Rosman, F. C., Chimelli, L., & Rehen, S. (2020) · doi:10.20944/preprints202009.0297.v1 · Cited by 51
“Although we cannot determine the relative contribution of SARS-CoV-2 infection to our patient’s encephalopathy, a recent study reported similar neurological complications of COVID-19 in previously healthy children, with or without co-infections [25] .”
Metadata
- Authors
- Lindan, C. E., Mankad, K., Ram, D., Kociolek, L. K., Silvera, V. M., Boddaert, N., Stivaros, S. M., Palasis, S., Akhtar, S., Alden, D., Amonkar, S., Aouad, P., Aubart, M., Bacalla, J. A., Barbosa, A. A., Basmaci, R., Berteloot, L., Blauwblomme, T., Brun, G., Carney, O., Chareyre, J., Chéron, G., Coimbra, P. P. D. A., Dangouloff-Ros, V., D'Arco, F., Dineen, R., De-Pontual, L., Desguerre, I., Elfallal, W., Evans, D. G., Ferraciolli, S. F., Girard, N., Gonçalves, F. G., Gonzalez, I., Grant, P. E., Grévent, D., Guimaraes, C. V. D. A., Hassell, J., Hirata, F. C. C., Kamaly-Asl, I., Jacob, J., Jackson, K., Jones, B. V., Joseph, R., Jung, A. Y., Kashgari, A., Kilday, J.-P., Kirsch, A., Kossorotoff, M., Krishnan, A., Kulkarni, S., Leruez-Vill, M., Lesage, F., Levy, R., Li, Y., Lima, C. C. D. V., Lingappa, L., Löbel, U., Lopez-Alberola, R., Lucato, L. T., Moreira, D. D., Murnick, J. G., Nahmani, S., Pagariya, S., Pavaine, J., Philbrook, B., Piovesan, A. C., Poisson, K. E., Reddy, N., Riley, P., Romsauerova, A., Roux, C.-J., Rugilo, C., Saigal, G., Salvador, G. L. D. O., Seidenwurm, D., Sermet-Gaudelus, I., Sidpra, J., Sudhakar, S. V., Toronchik, M. S., & Vézina, G.
- Venue
- The Lancet Child & Adolescent Health
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 5
- Issue
- 3
- Pages
- 167-177
- ISSN
- 2352-4642 (ISSN-L)
- OpenAlex
- W3111156757
- Cited by
- 215
- References
- 2
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. https://app.cochat.ai/papers/10.1016/s2352-4642(20)30362-x
- The paper
- Lindan, C. E., Mankad, K., Ram, D., Kociolek, L. K., Silvera, V. M., Boddaert, N., Stivaros, S. M., Palasis, S., Akhtar, S., Alden, D., Amonkar, S., Aouad, P., Aubart, M., Bacalla, J. A., Barbosa, A. A., Basmaci, R., Berteloot, L., Blauwblomme, T., Brun, G., . . . Vézina, G. (2021). Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(20)30362-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.